The Role of IL-33/ST2 Pathway in Tumorigenesis
Cancer is initiated by mutations in critical regulatory genes; however, its progression to malignancy is aided by non-neoplastic cells and molecules that create a permissive environment known as the tumor stroma or microenvironment (TME). Interleukin 33 (IL-33) is a dual function cytokine that also...
Main Authors: | Kristen M. Larsen, Maydelis Karla Minaya, Vivek Vaish, Maria Marjorette O. Peña |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/19/9/2676 |
Similar Items
-
IL-33 in Mental Disorders
by: Gianluca Pandolfo, et al.
Published: (2021-03-01) -
IL33 and Mast Cells—The Key Regulators of Immune Responses in Gastrointestinal Cancers?
by: Moritz F. Eissmann, et al.
Published: (2020-07-01) -
Blockade of IL‐33 signalling attenuates osteoarthritis
by: Zengliang He, et al.
Published: (2020-01-01) -
IL-33/ST2 Axis in Organ Fibrosis
by: Ourania S. Kotsiou, et al.
Published: (2018-10-01) -
The Dynamic Role of the IL-33/ST2 Axis in Chronic Viral-infections: Alarming and Adjuvanting the Immune Response
by: Vikram Mehraj, et al.
Published: (2016-07-01)